News
-
-
-
PRESS RELEASE
Revenue for 2025-2026, excluding the impact of the sale of EXPERF: EUR 526 million, exceeding the target 2025-2026 revenue as reported: EUR 483 million, up 7.6% Recurring operating margin target of around 9% confirmed
Groupe Bastide reports annual revenue for 2025-2026 with 7.6% growth, confirming recurring operating margin target. Strong performance in home healthcare services and positive outlook for 2026-2027 -
-
-
-
-
-
PRESS RELEASE
Completion of the disposal of New Medical Concept, the holding company of EXPERF Group, to Sapio Group
Bastide Group completes sale of New Medical Concept to Sapio Group, enhancing financial structure. Sapio aims for sustainable growth in healthcare sector with acquisition of EXPERF Group in France -